Pacira BioSciences (PCRX) Tax Provisions (2013 - 2026)
Pacira BioSciences (PCRX) posted quarterly Tax Provisions of $2.1 million for Q1 2026, down 46.53% year-over-year from $3.9 million in Q1 2025, and up 295.31% quarter-over-quarter from -$1.1 million in Q4 2025.
Pacira BioSciences (PCRX) Tax Provisions (2013 - 2026) Analysis & Trends
Pacira BioSciences' Tax Provisions history runs 14 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 46.53% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $8.0 million (down 77.5% YoY), while the FY2025 annual figure was $9.8 million, down 73.01% from the prior year.
- Tax Provisions for Q1 2026 stood at $2.1 million, up from -$1.1 million in the prior quarter.
- The five-year high for Tax Provisions was $17.7 million in Q2 2024, with the low at -$8.0 million in Q4 2022.
- The 5-year median for Tax Provisions is $3.9 million (2025), against an average of $3.9 million.
- Peak annual rise in Tax Provisions reached 467.39% in 2023, while the deepest fall reached 1588.84% in 2023.
- Pacira BioSciences' Tax Provisions stood at -$8.0 million in 2022, then soared by 211.1% to $8.8 million in 2023, then advanced by 7.18% to $9.5 million in 2024, then sank by 111.24% to -$1.1 million in 2025, then soared by 295.31% to $2.1 million in 2026.
- Business Quant data shows PCRX's Tax Provisions at $2.1 million in Q1 2026, -$1.1 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Pacira BioSciences | 948.27 Mn | 697.24 Mn | 148.24 Mn | -2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Dec 31, 2024 | 9.49 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 17.70 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | 8.85 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 12.09 Mn |
| Mar 31, 2023 | -6.94 Mn |
| Dec 31, 2022 | -7.97 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 466,000.00 |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | 6.57 Mn |